Skip to main content
51°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Cramer lists his major themes for the market in 2024
January 17, 2024
Tags
Investment strategy
NVIDIA Corp
Investment Strategy
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Health care industry
Zealand Pharma A/S
Breaking news
From
CNBC.com News
Cramer cheers Monday's tech gains, but tells investors to keep a diverse portfolio with an eye towards health care
January 08, 2024
Tags
Markets
Stock Picks
stocks
From
CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
January 08, 2024
Tags
Novo Nordisk A/S
Investing
Compute Health Acquisition Corp
From
CNBC.com News
Cramer's week ahead: Earnings season kicks off after JPMorgan Healthcare Conference
January 05, 2024
Tags
Investment Strategy
NVIDIA Corp
Amerisourcebergen Corp
From
CNBC.com News
Eli Lilly's direct drug sales may not upend the industry alone – but others could follow suit
January 05, 2024
Tags
Pharmaceuticals
Health & Science
WW International Inc
From
CNBC.com News
Here are the big health sector themes to watch next year
December 22, 2023
Tags
Novartis AG
Dexcom Inc
Business
From
CNBC.com News
10-year Treasury yield falls slightly on shorter trading day
December 22, 2023
Tags
Moderna Inc
World Markets
Bitcoin
From
CNBC.com News
10-year Treasury yield falls as investors continue to assess path ahead for rate cuts
December 21, 2023
Tags
Goldman Sachs Group Inc
Prices
Economic events
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Novo Nordisk A/S
US: News
Eli Lilly and Co
From
CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
December 20, 2023
Tags
US: News
Johnson & Johnson
U/S/ Markets
From
CNBC.com News
Treasury yields down slightly as recent trend continues
December 19, 2023
Tags
US Economy
Walgreens Boots Alliance Inc
Johnson & Johnson
From
CNBC.com News
5 things to know before the stock market opens Monday
December 18, 2023
Tags
FedEx Corp
Investment strategy
Technology
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Business
Health care industry
Breaking news
From
CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
December 11, 2023
Tags
Novo Nordisk A/S
US: News
Eli Lilly and Co
From
CNBC.com News
Treasury yields inch higher ahead of Fed meeting
December 11, 2023
Tags
Bonds
Breaking News: Markets
United Airlines Holdings Inc
From
CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
December 07, 2023
Tags
Pharmaceuticals
Breaking News: Politics
Health & Science
From
CNBC.com News
Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks
December 05, 2023
Tags
Foxconn Technology Co Ltd
Business
Investment Strategy
From
CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
December 05, 2023
Tags
Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
December 04, 2023
Tags
Investment Strategy
Investment strategy
Tyson Foods Inc
From
CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
December 02, 2023
Tags
Eisai Co Ltd
Sanofi SA
Science
From
CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
Tags
Health care industry
Business
Diabetes
From
CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
Tags
Eli Lilly and Co
US: News
Business News
From
CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
Tags
Pharmaceuticals
Health & Science
Eli Lilly and Co
From
CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
November 18, 2023
Tags
Target Corp
Markets
Apple Inc
From
CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
November 13, 2023
Tags
Stock Picks
Markets
stocks
From
CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
Tags
Pharmaceuticals
Health & Science
Novo Nordisk A/S
From
CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
November 10, 2023
Tags
ServiceNow Inc
Novo Nordisk A/S
U/S/ Markets
From
CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
Tags
Social issues
Eli Lilly and Co
US: News
From
CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
November 02, 2023
Tags
Business News
Biotechnology
Biotech and Pharmaceuticals
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.